Compare Pertamina Geothermal Energy Tbk. (PGEO) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pertamina Geothermal Energy Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Pertamina Geothermal Energy Tbk. trades at Rp1,025 (market cap 42.55T, 8.9M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pertamina Geothermal Energy Tbk. is far larger — about 407.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PGEO | SCPI | |
|---|---|---|
Market Cap | 42.55T | 104.4B |
Volume | 8.9M | — |
Lot | 88.99K | — |
Turnover | 8.99B | — |
Average Price | 1,010.29 | — |
Value | 8.99B | — |
Indicative Equilibrium Price | 1,025 | — |
Indicative Equilibrium Volume | 3.84K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pertamina Geothermal Energy Tbk.
PT Pertamina Geothermal Energy Tbk (the Company) was established on December 12, 2006 by Notarial Deed No. 10 of Marianne Vincentia Hamdani, S.H. The Company started its commercialoperations on January 3, 2007. The Company’s parent is PT Pertamina Power Indonesia and its ultimate parent is the Government of the Republic of Indonesia.
Read more on PGEO →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
